Measuring psychosis proneness in a nonclinical Korean population: is the Peters et al Delusions Inventory useful for assessing high-risk individuals?
We confirmed the reliability and validity of the Korean PDI-40. The usefulness of the PDI-40 in a nonclinical population was replicated in the Korean sample. The PDI-40 can be used as an informative device when investigating "psychosis proneness" in a group at high risk for psychosis.
Our data indicate that cilostazol treatment does not improve oxidative stress in PAD patients after 6 months of treatment. However, lipid peroxidation and total antioxidant capacity were affected by cilostrazol treatment, which could be related to altered reactive oxygen species production. Further research may be needed to determine the critical dose of cilostazol to clarify the protective role of this drug in PAD.